Stein-Merlob AF - Search Results

1

Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.

Stein-Merlob AF, Hara T, McCarthy JR, Mauskapf A, Hamilton JA, Ntziachristos V, Libby P, Jaffer FA. Stein-Merlob AF, et al. Circ Cardiovasc Imaging. 2017 May;10(5):e005813. doi: 10.1161/CIRCIMAGING.116.005813. Circ Cardiovasc Imaging. 2017. PMID: 28487316 Free PMC article.

2

Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.

Stein-Merlob AF, Kessinger CW, Erdem SS, Zelada H, Hilderbrand SA, Lin CP, Tearney GJ, Jaff MR, Reed GL, Henke PK, McCarthy JR, Jaffer FA. Stein-Merlob AF, et al. Theranostics. 2015 Sep 13;5(12):1317-27. doi: 10.7150/thno.12494. eCollection 2015. Theranostics. 2015. PMID: 26516370 Free PMC article.

3

T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies.

Stein-Merlob AF, Ganatra S, Yang EH. Stein-Merlob AF, et al. Heart Fail Clin. 2022 Jul;18(3):443-454. doi: 10.1016/j.hfc.2022.02.008. Heart Fail Clin. 2022. PMID: 35718418 Review.

4

Novel Therapeutics for Anthracycline Induced Cardiotoxicity.

Vuong JT, Stein-Merlob AF, Cheng RK, Yang EH. Vuong JT, et al. Among authors: stein merlob af. Front Cardiovasc Med. 2022 Apr 22;9:863314. doi: 10.3389/fcvm.2022.863314. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35528842 Free PMC article. Review.

5

Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

Vuong JT, Stein-Merlob AF, Nayeri A, Sallam T, Neilan TG, Yang EH. Vuong JT, et al. Among authors: stein merlob af. J Am Coll Cardiol. 2022 Feb 15;79(6):577-593. doi: 10.1016/j.jacc.2021.11.048. J Am Coll Cardiol. 2022. PMID: 35144750 Free PMC article. Review.

6

Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery.

Stein-Merlob AF, Hsu JJ, Colton B, Berg CJ, Ferreira A, Price MM, Wainberg Z, Baas AS, Deng MC, Parikh RV, Yang EH. Stein-Merlob AF, et al. ESC Heart Fail. 2021 Oct;8(5):4301-4306. doi: 10.1002/ehf2.13545. Epub 2021 Aug 13. ESC Heart Fail. 2021. PMID: 34390221 Free PMC article.

7

Cardiotoxicities of novel cancer immunotherapies.

Stein-Merlob AF, Rothberg MV, Ribas A, Yang EH. Stein-Merlob AF, et al. Heart. 2021 Nov;107(21):1694-1703. doi: 10.1136/heartjnl-2020-318083. Epub 2021 Mar 15. Heart. 2021. PMID: 33722826 Review.

8

Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies.

Stein-Merlob AF, Rothberg MV, Holman P, Yang EH. Stein-Merlob AF, et al. Curr Cardiol Rep. 2021 Jan 22;23(3):11. doi: 10.1007/s11886-021-01440-3. Curr Cardiol Rep. 2021. PMID: 33483873 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page